These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20717915)

  • 21. Decline in lung function does not predict future decline in lung function in cystic fibrosis patients.
    Rosenfeld M; VanDevanter DR; Ren CL; Elkin EP; Pasta DJ; Konstan MW; Morgan WJ;
    Pediatr Pulmonol; 2015 Sep; 50(9):856-62. PubMed ID: 26086901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early-Life Height Attainment in Cystic Fibrosis Is Associated with Pulmonary Function at Age 6 Years.
    Sanders DB; Slaven JE; Maguiness K; Chmiel JF; Ren CL
    Ann Am Thorac Soc; 2021 Aug; 18(8):1335-1342. PubMed ID: 33476226
    [No Abstract]   [Full Text] [Related]  

  • 23. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?
    Kapur N; Masters IB; Chang AB
    Chest; 2010 Jul; 138(1):158-64. PubMed ID: 20173055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.
    Sanders DB; Emerson J; Ren CL; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1170-6. PubMed ID: 26288390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis.
    Schneiderman JE; Wilkes DL; Atenafu EG; Nguyen T; Wells GD; Alarie N; Tullis E; Lands LC; Coates AL; Corey M; Ratjen F
    Eur Respir J; 2014 Mar; 43(3):817-23. PubMed ID: 24176992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for onset of persistent respiratory symptoms in children with cystic fibrosis.
    McColley SA; Ren CL; Schechter MS; Regelmann WE; Pasta DJ; Konstan MW;
    Pediatr Pulmonol; 2012 Oct; 47(10):966-72. PubMed ID: 22359344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
    Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
    Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
    Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
    J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral.
    Rosenbluth DB; Wilson K; Ferkol T; Schuster DP
    Chest; 2004 Aug; 126(2):412-9. PubMed ID: 15302726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.
    Kerem E; Corey M; Gold R; Levison H
    J Pediatr; 1990 May; 116(5):714-9. PubMed ID: 2109790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.
    Kosorok MR; Zeng L; West SE; Rock MJ; Splaingard ML; Laxova A; Green CG; Collins J; Farrell PM
    Pediatr Pulmonol; 2001 Oct; 32(4):277-87. PubMed ID: 11568988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis.
    Sawicki GS; Rasouliyan L; Pasta DJ; Regelmann WE; Wagener JS; Waltz DA; Ren CL
    Pediatr Pulmonol; 2008 Nov; 43(11):1117-1123. PubMed ID: 18846559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.
    Sanders DB; Bittner RC; Rosenfeld M; Hoffman LR; Redding GJ; Goss CH
    Am J Respir Crit Care Med; 2010 Sep; 182(5):627-32. PubMed ID: 20463179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005.
    VanDevanter DR; Rasouliyan L; Murphy TM; Morgan WJ; Ren CL; Konstan MW; Wagener JS;
    Pediatr Pulmonol; 2008 Aug; 43(8):739-44. PubMed ID: 18613041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright C; Smyth AR
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Course of Illness after Viral Infection in Indian Children with Cystic Fibrosis.
    Gulla KM; Balaji A; Mukherjee A; Jat KR; Sankar J; Lodha R; Kabra SK
    J Trop Pediatr; 2019 Apr; 65(2):176-182. PubMed ID: 29893951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    Polineni D; Piccorelli AV; Hannah WB; Dalrymple SN; Pace RG; Durie PR; Ling SC; Knowles MR; Stonebraker JR
    PLoS One; 2018; 13(10):e0205257. PubMed ID: 30307979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of medical practice in cystic fibrosis: part I. Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Konstan MW; Butler SM; Schidlow DV; Morgan WJ; Julius JR; Johnson CA
    Pediatr Pulmonol; 1999 Oct; 28(4):242-7. PubMed ID: 10497372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Geller DE; Kaplowitz H; Light MJ; Colin AA
    Chest; 1999 Sep; 116(3):639-46. PubMed ID: 10492265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis.
    Kim JS; Okamoto K; Rubin BK
    Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.